๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Long-term therapy of paget's disease of bone with ehdp

โœ Scribed by Ethel S. Siris; Robert E. Canfield; Thomas P. Jacobs; Delia C. Baquiran

Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
790 KB
Volume
23
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Use of etidronate (ehdp) in paget's dise
Use of etidronate (ehdp) in paget's disease of bone
โœ C. Conrad Johnston Jr; M. R. A. Khairi; P. J. Meunier ๐Ÿ“‚ Article ๐Ÿ“… 1980 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 382 KB ๐Ÿ‘ 1 views

## Abstract Etidronate used in recommended doses (usually 5 mg/kg/day for 6 months) produces symptomatic improvement in approximately 60% of patients. The serum alkaline phosphatase and urinary hydroxyproline are reduced to about 50% of initial values. A sustained remission occurs in many patients

Long-Term Outcome of Perianal Pagetโ€™s Di
Long-Term Outcome of Perianal Pagetโ€™s Disease
โœ MartinD. McCarter; StuartH. Q. Quan; Klaus Busam; PhilipP. Paty; Douglas Wong; J ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› Springer ๐ŸŒ English โš– 141 KB